Celidwen et al. provide a framework to consider more respectful relationships between Western institutions and Indigenous psychedelic medicines, with a view to resist extraction and commercialisation.
Drugs, Habits and Social Policy dedicates a special issue to present some of the latest insights into this harm reduction practice and explore enduring limitations of the scientific literature to date.
Ivsins et al. find overwhelming participant support for these services whilst shedding light on the mediating influence of physical environments, social resources and various structural forces.
Craft et al. find no clear evidence that exposure to analytically confirmed synthetic cannabinoids increased or decreased after implementing the Psychoactive Substances Act 2016.
IDPC highlights how the increasing involvement of UN human rights entities in drug policy debates has paved the way for greater, yet still insufficient, consideration of health, human rights and development.
The publication offers insights into how the PARTY project organised and implemented online harm reduction interventions working with e-volunteers and harm reduction experts.
The Penington Institute discusses medicinal access, reducing the harms associated with current laws and substance use, and ideas towards more compassionate frameworks.
This publication provides insights into patterns of drug use, levels of knowledge and risk perception on HIV, HCV and TB, as well as barriers and facilitators to access related programmes.
IDPC welcomes the report’s impressive range of data and analysis, as well as its attention to environmental impacts; but regrets the continued lack of acknowledgement of the destructive impact of punitive drug policies, related human rights abuses and opportunities for meaningful reform.
